Real-Life Effectiveness and Tolerability of Vildagliptin and Other Oral Glucose-Lowering Therapies in Patients with Type 2 Diabetes in Germany

INTRODUCTION: Metformin is an established first-line treatment for patients with type 2 diabetes mellitus (T2DM), but treatment intensification with other oral antidiabetes drugs (OADs) is usually required over time. Effectiveness of diabetes control with vildagliptin and vildagliptin/metformin was...

Descripción completa

Detalles Bibliográficos
Autores principales: Göke, Rüdiger, Bader, Giovanni, Dworak, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065295/
https://www.ncbi.nlm.nih.gov/pubmed/24643724
http://dx.doi.org/10.1007/s13300-014-0060-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065295/
https://www.ncbi.nlm.nih.gov/pubmed/24643724
http://dx.doi.org/10.1007/s13300-014-0060-4

Ejemplares similares